Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $3.86 million. The enterprise value is -$2.30 million.
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 1.62 million shares outstanding. The number of shares has increased by 286.75% in one year.
| Current Share Class | 1.62M |
| Shares Outstanding | 1.62M |
| Shares Change (YoY) | +286.75% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 2.72% |
| Float | 1.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.11 |
| Forward PS | 0.14 |
| PB Ratio | 0.05 |
| P/TBV Ratio | 0.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.22 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.32% and return on invested capital (ROIC) is -12.47%.
| Return on Equity (ROE) | -27.32% |
| Return on Assets (ROA) | -10.02% |
| Return on Invested Capital (ROIC) | -12.47% |
| Return on Capital Employed (ROCE) | -20.76% |
| Weighted Average Cost of Capital (WACC) | 9.58% |
| Revenue Per Employee | $709,866 |
| Profits Per Employee | -$120,789 |
| Employee Count | 50 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 1.90 |
Taxes
In the past 12 months, SBFM has paid $61,770 in taxes.
| Income Tax | 61,770 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.29% in the last 52 weeks. The beta is 1.31, so SBFM's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -83.29% |
| 50-Day Moving Average | 8.67 |
| 200-Day Moving Average | 12.82 |
| Relative Strength Index (RSI) | 28.66 |
| Average Volume (20 Days) | 4,147,122 |
Short Selling Information
The latest short interest is 496,125, so 30.69% of the outstanding shares have been sold short.
| Short Interest | 496,125 |
| Short Previous Month | 104,141 |
| Short % of Shares Out | 30.69% |
| Short % of Float | 30.88% |
| Short Ratio (days to cover) | 2.88 |
Income Statement
In the last 12 months, SBFM had revenue of $35.49 million and -$6.04 million in losses. Loss per share was -$12.83.
| Revenue | 35.49M |
| Gross Profit | 11.71M |
| Operating Income | -4.58M |
| Pretax Income | -5.98M |
| Net Income | -6.04M |
| EBITDA | -4.23M |
| EBIT | -4.58M |
| Loss Per Share | -$12.83 |
Full Income StatementBalance Sheet
The company has $6.91 million in cash and $744,840 in debt, with a net cash position of $6.17 million or $3.82 per share.
| Cash & Cash Equivalents | 6.91M |
| Total Debt | 744,840 |
| Net Cash | 6.17M |
| Net Cash Per Share | $3.82 |
| Equity (Book Value) | 21.52M |
| Book Value Per Share | 43.83 |
| Working Capital | 18.91M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.71 million and capital expenditures -$172,130, giving a free cash flow of -$5.88 million.
| Operating Cash Flow | -5.71M |
| Capital Expenditures | -172,130 |
| Depreciation & Amortization | 344,136 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.88M |
| FCF Per Share | -$3.64 |
Full Cash Flow StatementMargins
Gross margin is 32.98%, with operating and profit margins of -12.90% and -17.02%.
| Gross Margin | 32.98% |
| Operating Margin | -12.90% |
| Pretax Margin | -16.84% |
| Profit Margin | -17.02% |
| EBITDA Margin | -11.93% |
| EBIT Margin | -12.90% |
| FCF Margin | n/a |
